Resources

Featured:

April 9, 2013

Patent No.: US 8413800B2 & Patent Date: 9 April 2013

March 13, 2013

UTHealth researchers say more rapid test for Group B strep successful

Feb 20, 2013

NanoLogix Bacteria Detection Plates Break Longevity Records Using Anthrax as Reference Bacteria


The results of a study for rapid TB detection and identification by a major third-party research facility utilizing NanoLogix BioNanoPore (BNP) technology have been published in the Journal of Microbial & Biochemical Technology

Third party study utilizing Nanologix BNP Technology - December 13, 2012 

The results of a study for rapid TB detection and identification by a major third-party research facility utilizing NanoLogix BioNanoPore (BNP) technology have been published in the Journal of Microbial & Biochemical Technology

Read more>>


Central Association of Obstetricians and Gynecologists . 2012 Annual Meeting

Poster Presentation - October 17-20, 2012 

Group B Strep research from University of Texas Health Science Center

Jonathan Faro presents one hour results utilizing a refined BNF Assay.

View the poster here>>


Society for Maternal-Fetal Medicine’s 32rd Annual Meeting

Third-Party Details on Tests of NanoLogix Petri "Flat Pack" Shelf-Life

April 24, 2012 -- In a statement from the independent testing lab:

“NNLX differentiated their product with unique packaging.  Deemed as “the flat-pack,” ten monoplates are arranged in a sturdy, honey-combed configuration as a single layer (i.e., plates were not stacked atop each other).  Also, the polymer wrapper bag was sealed with a vacuum, further enhancing the sturdiness of the packaging.  The other vendors typically stack the monoplates in quantities of ten, resulting in a cylindrical configuration.  Also, these cylindrical packs do not exhibit any form of vacuum seal.  As a result, heavy condensation can be an issue inside the monoplates themselves.  Also, vendors have had issues with monoplate breakage during the course of shipping.  The Petri-dish is made from polystyrene plastic and can be susceptible to damage if the shipping box is roughly handled.  None of the NNLX flat-packs were damaged or exhibited excess condensation.

The shelf-life test involved plating purified Bacillus anthracis Ames spores on TSA provided by a third party vendor and the use of the same dilutions to plate the spores onto NNLX TSA from flat-packs.  Colonies were enumerated after 18-24 hours of incubation at 37±2°C.  The quantitative values from the third party vendor were directly compared to those from the NNLX TSA from flat-packs.  Also, this head-to-head evaluation spanned over the course of 12 months (from April 2011 to March 2012).  The results showed that the average colony forming units per milliliter (CFU/mL) of spores plated onto the third party vendor TSA product was 1.07 x 10 to the 9th CFU/mL.  The NNLX TSA averaged 9.60 x 10 to the 8th CFU/mL.  The coefficient of variance of 7.47% is within the acceptable criteria for enumerated colonies. The results are interesting since third party vendors’ shelf-life have typically been three months for TSA.  Beyond the three months may result in drying or desiccation of the media exhibited by a thinner agar layer.  Whereas, the NNLX TSA flat-packs appeared to have maintained the initial agar thickness over the course of 12 months, and the enumeration results suggest that the nutrients within the BD Soybean-Casein that NNLX used were sufficient to promote similar colony growth to that of a third party vendor’s TSA with a shorter shelf-life.”

 

January 12, 2012: NanoLogix Joins WHO StopTB Partnership

NanoLogix is pleased to announce it has been accepted as a member to the World Health Organization’s Stop TB Partnership. The organization consists of nearly 1000 partner members who are a collective force that is transforming the fight against TB in more than 100 countries. They include international and technical organizations, government programs, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector. More information on NanoLogix membership in the StopTB Partnership can be found at http://www.stoptb.org/partners/partner_profile2.asp?PID=69342.

 


Society for Gynecologic Investigation - 2012 Annual Scientific Meeting

Poster Presentation - March 21-24, 2012 

Group B Strep research from University of Texas Health Science Center

Dr. Jonathan Faro, lead physician on the research states, "We were very happy to have had the opportunity to present our poster at the 59th annual scientific meeting of the Society for Gynecologic Investigation in San Diego. This was a terrific opportunity to share our research with other investigators, and we were happy to see that our initial data showing that GBS may be detected in under one hour was well received. There was a genuine interest by several clinicians in this assay, and we hope to provide them with further data in the near future."

View the poster here>>


Society for Maternal-Fetal Medicine’s 32rd Annual Meeting

Poster Presentation - February 6-11, 2012

Group B Strep research from University of Texas Health Science Center

View the poster here>>


American Journal of Perinatology

(August 2011- online, November 2011- print)

"Rapid Diagnostic Test for Identifying Group B Streptococcus"

<Abstract>       <Full Report>

Peer-reviewed study from the University of Teas Health Science Center - Houston establishes rapid growth and detection of Group B Streptococcus can be performed in four to six hours using NanoLogix BNP and BNF Quick Test technology. This is in marked contrast to the 48 to 72 hours required by current methods.


Cooperative Research and Development Agreement

New CRADA expected to enhance EPA ability to detect E. coli and Cryptosporidium in source waters

(July 7, 2010)

 


Letters in Applied Microbiology

“Decreased time for detection and quantification of virulent Bacillus anthracis and Yersinia pestis using a BioNanoPore (BNP™) membrane technology”

An independent study by a leading biodefense and biomedical research agency in Columbus found that NanoLogix's BNP™ Ultra-Fast Identification Technology allows for the viewing of anthrax cultures four times faster than conventional methods and the viewing of bubonic plague cultures twice as fast.

(April 2009)